Feasibility and Safety of a Wireless Palpator

Launched by LONDON HEALTH SCIENCES CENTRE RESEARCH INSTITUTE OR LAWSON RESEARCH INSTITUTE OF ST. JOSEPH'S · Apr 4, 2022

Keywords

ClinConnect Summary

This clinical trial is looking at a new device called a Wireless Palpator, which helps doctors find small lung tumors that are hard to see or feel using regular methods. The goal is to see if this device can detect hidden lung tumors before surgery, particularly for patients with a type of lung nodule that is over 5 mm but less than 50 mm in size.

To be eligible for the study, participants must be at least 18 years old and scheduled for surgery to remove a specific type of lung nodule. However, those with certain types of nodules that are easier to locate, pregnant women, and individuals who cannot give consent will not be able to join. If you participate, you will help researchers understand how well this new device works, which could improve the way lung cancers are diagnosed and treated in the future. The trial is not yet recruiting participants, so more information will be available as it gets underway.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age \> 18 years
• • Peripheral occult sub-pleural (\>5 mm) solitary lung nodule \< 50 mm on CT scan scheduled for surgical removal using a VATS approach
• Exclusion Criteria:
• • Semi-solid nodules (ground glass nodule).
• • Pregnancy or potentially pregnant women.
• • Mentally challenged.
• • Inability to consent for the study.
• • Patients less than 18 years old.
• • Patients with pulmonary nodules easily located during VATS (\> 50 mm, pleural puckering, invading chest wall)
• • Patients who have chest anatomy precluding VATS resection.